结果页面 11，行业：生物技术，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
所有国家
所有交流
- {{item.name}}
- 所有交流
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
所有版块
- {{item.name}}
- 所有版块
- 医疗保健 (2611)
生物技术 (2611)
- {{item.name}}
- 所有行业
- 农业投入 (323)
- 建筑材料 (471)
- 化学品 (605)
- 特种化学品 (1353)
- 木材和木材生产 (160)
- 纸和纸制品 (269)
- 铝 (141)
- 铜 (216)
- 其他工业金属和采矿 (2765)
- 金 (1700)
- 银 (84)
- 其他贵金属和采矿 (660)
- 炼焦煤 (71)
- 钢 (744)
- 汽车和卡车经销商 (212)
- 汽车制造商 (388)
- 汽车零部件 (1166)
- 休闲车 (85)
- 家具、固定装置和器具 (507)
- 住宅建筑 (214)
- 纺织品制造 (520)
- 服装制造 (444)
- 鞋类和配件 (208)
- 包装和容器 (481)
- 个人服务 (140)
- 餐厅 (539)
- 服装零售 (289)
- 百货商店 (276)
- 家居装饰零售 (106)
- 奢侈品 (260)
- 互联网零售 (408)
- 专业零售 (547)
- 博彩 (205)
- 休闲 (411)
- 住宿 (321)
- 度假村和赌场 (188)
- 旅行服务 (192)
- 资产管理 (1966)
- 银行 – 多元化 (308)
- 银行 – 区域 (2297)
- 抵押贷款融资 (171)
- 资本市场 (888)
- 金融数据和股票交易所 (151)
- 保险 – 人寿 (260)
- 保险 – 财产和意外伤害 (270)
- 保险 – 再保险 (74)
- 保险 – 专业 (72)
- 保险经纪人 (67)
- 保险 – 多元化 (306)
- 空壳公司 (1820)
- 金融集团 (100)
- 信贷服务 (660)
- 房地产 – 开发 (966)
- 房地产服务 (1145)
- 房地产 – 多元化 (316)
- 房地产投资信托 – 医疗保健设施 (64)
- 房地产投资信托 – 酒店和汽车旅馆 (86)
- 房地产投资信托 – 工业 (141)
- 房地产投资信托 – 办公室 (169)
- 房地产投资信托 – 住宅 (108)
- 房地产投资信托 – 零售 (230)
- 房地产投资信托 – 抵押贷款 (130)
- 房地产投资信托 – 专业 (83)
- 房地产投资信托 – 多元化 (332)
- 酒水 – 啤酒制造商 (162)
- 酒水 – 酒庄和酿酒厂 (242)
- 酒水 – 非酒精类 (217)
- 糖果商 (170)
- 农产品 (610)
- 家用和个人用品 (523)
- 包装食品 (1270)
- 教育和培训服务 (305)
- 折扣店 (97)
- 食品配送 (210)
- 食品杂货店 (233)
- 烟草 (105)
- 生物技术 (2611)
- 药品制造商 – 仿制药 (279)
- 药品制造商 – 特药和仿制药 (1705)
- 医疗保健计划 (57)
- 医疗保健设施 (553)
- 医药零售商 (155)
- 健康信息服务 (419)
- 医疗器械 (913)
- 医疗仪器和用品 (501)
- 诊断和研究 (427)
- 医药分销 (138)
- 公用事业 – 独立发电公司 (170)
- 公用事业 – 可再生能源 (561)
- 公用事业 – 管制水 (173)
- 公用事业 – 管制电 (468)
- 公用事业 – 管制天然气 (205)
- 公用事业 – 多元化 (214)
- 电信服务 (910)
- 广告代理机构 (508)
- 出版 (259)
- 广播 (213)
- 娱乐 (679)
- 互联网内容和信息 (530)
- 电子游戏和多媒体 (484)
- 石油和天然气钻探 (80)
- 石油和天然气勘探与生产 (1185)
- 石油和天然气一体化 (246)
- 石油和天然气中游 (230)
- 石油和天然气精炼与营销 (278)
- 石油和天然气设备与服务 (480)
- 热能煤 (229)
- 铀 (140)
- 航空航天与国防 (560)
- 专业商业服务 (640)
- 咨询服务 (195)
- 出租和租赁服务 (219)
- 安全与保护服务 (267)
- 人事与就业服务 (252)
- 综合性企业 (723)
- 工程与建筑 (1492)
- 基础设施运营 (156)
- 建筑产品和设备 (513)
- 农用和重型工程机械 (376)
- 工业分销 (235)
- 商业设备和用品 (142)
- 特种工业机械 (1720)
- 金属加工 (393)
- 污染与处理控制 (265)
- 工具和配件 (240)
- 电气设备与零件 (897)
- 机场和航空服务 (135)
- 航空公司 (229)
- 铁路 (260)
- 海运 (505)
- 货车运输 (99)
- 综合货运与物流 (388)
- 废物管理 (354)
- 信息技术服务 (1178)
- 软件 – 应用程序 (2113)
- 软件 – 基础设施 (955)
- 通信设备 (731)
- 计算机硬件 (434)
- 消费电子产品 (282)
- 电子元器件 (971)
- 电子和计算机分销 (239)
- 科学技术仪器 (347)
- 半导体设备与材料 (350)
- 半导体 (611)
- 太阳能 (222)
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| GlobeStar Therapeutics GSTC | $0 — |
0
|
$1.24K — | $1.1M — | $0 — | $0 — | $1.24K — | 0 | $0 — | |
| Amarantus BioScience AMBS | $0 — |
-99.67
|
$1.05K — | $1.5K — | $0 — | $0 — | $1.05K — | 0 | -$0.02 — | |
| Braxia Scientific BRAXF | $0 — |
-99
|
$795 — | $59.7K — | $0 — | $0 — | $795 — | 0 | -$0.04 — | |
| NLS Pharmaceutics NLSPW | $0.02999 — |
+85.71
|
$0 — | $33.7K — | $0.02 — | $0.04 — | $0 — | 0 | $0 — | |
| Novo Nordisk A/S N1VO34.SA | $51.67 10.47 USD |
+0.33
|
$1.84T 372.27B USD | $20 4.05 USD | $51.67 10.47 USD | $51.67 10.47 USD | $1.84T 372.27B USD | 20.42 | $2.53 0.51 USD | |
| Novo Nordisk A/S NOVA.F | $64.3 70.29 USD |
+2.06
|
$289.85B 316.84B USD | $271 296.24 USD | $63 68.87 USD | $64.4 70.4 USD | $289.85B 316.84B USD | 20.41 | $3.15 3.44 USD | |
| Novo Nordisk A/S NVON.MX | $1,385.01 82.01 USD |
-0.42
|
$3.19T 189.13B USD | $2.43K 144 USD | $1,385.01 82.01 USD | $1,385.01 82.01 USD | $3.19T 189.13B USD | 22.30 | $62.09 3.68 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $8,784 520.12 USD |
0
|
$2.26T 133.57B USD | $0 0 USD | $8,784 520.12 USD | $8,784 520.12 USD | $2.26T 133.57B USD | 0 | -$73.79 -4.3 USD | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $633.47 128.39 USD |
0
|
$650.69B 131.88B USD | $0 0 USD | $633.47 128.39 USD | $633.47 128.39 USD | $650.69B 131.88B USD | 0 | -$5.38 -1.09 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $392.75 429.33 USD |
-0.19
|
$100.86B 110.25B USD | $4 4.37 USD | $389.6 425.89 USD | $393.6 430.26 USD | $100.86B 110.25B USD | 0 | -$3.34 -3.6 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $391.8 428.29 USD |
-0.05
|
$100.61B 109.98B USD | $66 72.15 USD | $390.8 427.2 USD | $392 428.51 USD | $100.61B 109.98B USD | 0 | -$3.33 -3.6 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $390.55 426.92 USD |
-0.04
|
$100.54B 109.91B USD | $5 5.47 USD | $389.8 426.1 USD | $390.55 426.92 USD | $100.54B 109.91B USD | 0 | -$3.36 -3.6 USD | |
| CSL CMXHF | $164.94 — |
0
|
$79.87B — | $39 — | $164.94 — | $166.3 — | $79.87B — | 30.31 | $5.44 — | |
| CSL Limited CSJA.F | $68 74.33 USD |
-1.45
|
$66.73B 72.95B USD | $5 5.47 USD | $68 74.33 USD | $68 74.33 USD | $66.73B 72.95B USD | 28.45 | $2.39 2.61 USD | |
| CSL Limited CSJ.F | $136.78 149.52 USD |
-1.47
|
$66.72B 72.93B USD | $50 54.66 USD | $136.78 149.52 USD | $136.78 149.52 USD | $66.72B 72.93B USD | 28.55 | $4.79 5.24 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $45.7 9.26 USD |
+0.46
|
$296.69B 60.13B USD | $60 12.16 USD | $45.7 9.26 USD | $45.7 9.26 USD | $296.69B 60.13B USD | 12.35 | $3.7 0.75 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $9,485 561.63 USD |
0
|
$1.01T 59.69B USD | $178 10.54 USD | $9,485 561.63 USD | $9,485 561.63 USD | $1.01T 59.69B USD | 12.51 | $757.85 44.87 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $1,019,000 769.18 USD |
-1.45
|
$72.53T 54.75B USD | $90.87K 68.59 USD | $1,015,000 766.16 USD | $1,040,000 785.03 USD | $72.53T 54.75B USD | 0 | $0 0 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $429.9 469.94 USD |
-0.92
|
$45.63B 49.88B USD | $0 0 USD | $427.9 467.75 USD | $429.9 469.94 USD | $45.63B 49.88B USD | 12.51 | $34.36 37.56 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $86.28 17.49 USD |
-0.02
|
$225B 45.6B USD | $0 0 USD | $0 0 USD | $0 0 USD | $225B 45.6B USD | 0 | -$0.6 -0.1 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| argenx SE A1RG34.SA | $131.95 26.74 USD |
0
|
$201.42B 40.82B USD | $0 0 USD | $131.95 26.74 USD | $131.95 26.74 USD | $201.42B 40.82B USD | 35.75 | $3.69 0.75 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $264.9 289.57 USD |
+0.08
|
$35B 38.26B USD | $37 40.45 USD | $264.9 289.57 USD | $264.9 289.57 USD | $35B 38.26B USD | 0 | -$1.85 -2.02 USD | |
| argenx SE ARGNF | $562 — |
+2
|
$35.63B — | $10 — | $562 — | $562 — | $35.63B — | 34.24 | $16.41 — | |
| UCB SA UCBJF | $179.39 — |
+2.07
|
$34.59B — | $84 — | $179.39 — | $179.39 — | $34.59B — | 28.56 | $6.28 — | |
| argenx SE ARGX.VI | $506.4 553.56 USD |
-0.35
|
$31.01B 33.89B USD | $0 0 USD | $505.8 552.91 USD | $509.8 557.28 USD | $31.01B 33.89B USD | 35.33 | $14.33 15.66 USD | |
| UCB SA UCB.VI | $162.45 177.58 USD |
+0.93
|
$30.87B 33.75B USD | $0 0 USD | $161.9 176.98 USD | $163 178.18 USD | $30.87B 33.75B USD | 29.69 | $5.47 5.98 USD | |
| argenx SE 1AEA.F | $496 542.2 USD |
-0.8
|
$30.87B 33.74B USD | $9 9.84 USD | $496 542.2 USD | $496 542.2 USD | $30.87B 33.74B USD | 34.44 | $14.4 15.74 USD | |
| argenx SE 1AE.F | $502 548.75 USD |
-1.1
|
$30.77B 33.64B USD | $10 10.93 USD | $502 548.75 USD | $502 548.75 USD | $30.77B 33.64B USD | 34.81 | $14.42 15.76 USD | |
| UCB SA UNC.F | $161.05 176.05 USD |
-0.37
|
$30.61B 33.46B USD | $15 16.4 USD | $161.05 176.05 USD | $161.05 176.05 USD | $30.61B 33.46B USD | 29.38 | $5.48 5.99 USD | |
| UCB SA UNC0.F | $79.5 86.9 USD |
+1.27
|
$30.59B 33.44B USD | $50 54.66 USD | $79.5 86.9 USD | $79.5 86.9 USD | $30.59B 33.44B USD | 29.01 | $2.74 3 USD | |
| BioNTech SE B1NT34.SA | $39.56 8.02 USD |
0
|
$152.16B 30.84B USD | $0 0 USD | $39.56 8.02 USD | $39.56 8.02 USD | $152.16B 30.84B USD | 0 | -$1.28 -0.2 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $27.27B 29.81B USD | 0 | $0 0 USD | |
| BeOne Medicines Ltd. 49BA.F | $222 242.68 USD |
-0.89
|
$25.63B 28.02B USD | $25 27.33 USD | $222 242.68 USD | $222 242.68 USD | $25.63B 28.02B USD | 0 | -$3.2 -3.4 USD | |
| BeOne Medicines Ltd. 49B.F | $16.51 18.04 USD |
-1.96
|
$25.36B 27.72B USD | $509 556.41 USD | $16.51 18.04 USD | $16.51 18.04 USD | $25.36B 27.72B USD | 0 | -$0.25 -0.2 USD | |
| Celltrion, Inc. 068270.KS | $163,100 123.11 USD |
+1.62
|
$35.51T 26.8B USD | $529.38K 399.6 USD | $160,200 120.92 USD | $163,400 123.34 USD | $35.51T 26.8B USD | 0 | $0 0 USD | |
| BioNTech SE BNTX.VI | $98.75 107.95 USD |
-0.1
|
$23.74B 25.95B USD | $255 278.75 USD | $98.4 107.56 USD | $99.6 108.88 USD | $23.74B 25.95B USD | 0 | -$3.19 -3.4 USD | |
| BioNTech SE 22UA.F | $98.6 107.78 USD |
-0.25
|
$23.7B 25.91B USD | $1.57K 1.72K USD | $97.75 106.85 USD | $99.9 109.2 USD | $23.7B 25.91B USD | 0 | -$3.19 -3.4 USD | |
| BeiGene, Ltd. B1GN34.SA | $44.65 9.05 USD |
0
|
$123.42B 25.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $123.42B 25.02B USD | 0 | $0 0 USD | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.66B 23.68B USD | 0 | $0 0 USD | |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — | |
| Royalty Pharma plc RPD.F | $29.02 31.72 USD |
+0.1
|
$16.53B 18.07B USD | $15 16.4 USD | $29.02 31.72 USD | $29.02 31.72 USD | $16.53B 18.07B USD | 13.49 | $2.15 2.35 USD | |
| Royalty Pharma plc RPD.MU | $29.07 31.78 USD |
0
|
$16.52B 18.05B USD | $0 0 USD | $29.07 31.78 USD | $29.07 31.78 USD | $16.52B 18.05B USD | 13.52 | $2.15 2.35 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,480 87.63 USD |
0
|
$283.83B 16.81B USD | $0 0 USD | $1,480 87.63 USD | $1,480 87.63 USD | $283.83B 16.81B USD | 28.48 | $51.95 3.08 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.26B 16.68B USD | 0 | $0 0 USD | |
| Innovent Biologics IVBXF | $8.25 — |
+5.68
|
$15.5B — | $1.59K — | $8 — | $8.25 — | $15.5B — | 0 | -$0.01 — | |
| Incyte Corporation I1NC34.SA | $171.27 34.71 USD |
0
|
$73.62B 14.92B USD | $0 0 USD | $171.27 34.71 USD | $171.27 34.71 USD | $73.62B 14.92B USD | 300.47 | $0.57 0.12 USD | |
| Incyte Corporation INCY.MX | $1,180.69 69.91 USD |
0
|
$251.28B 14.88B USD | $0 0 USD | $0 0 USD | $0 0 USD | $251.28B 14.88B USD | 302.74 | $3.9 0.23 USD | |
| United Therapeutics Corporation UTH.F | $281.6 307.83 USD |
-0.53
|
$12.77B 13.96B USD | $15 16.4 USD | $281.6 307.83 USD | $281.6 307.83 USD | $12.77B 13.96B USD | 12.77 | $22.05 24.1 USD | |
| Innovent Biologics, Inc. 6IB.F | $7.75 8.47 USD |
-8.82
|
$12.7B 13.88B USD | $4.69K 5.13K USD | $7.75 8.47 USD | $7.95 8.69 USD | $12.7B 13.88B USD | 0 | -$0.01 -0.01 USD | |
| Genmab A/S GNMSF | $212 — |
+2.05
|
$13.52B — | $140 — | $211.5 — | $216 — | $13.52B — | 12.44 | $17.04 — | |
| Insmed Incorporated IM8N.F | $67 73.24 USD |
+4.69
|
$12.34B 13.49B USD | $130 142.11 USD | $64.5 70.51 USD | $67 73.24 USD | $12.34B 13.49B USD | 0 | -$5.21 -5.6 USD | |
| Insmed Incorporated IM8N.SG | $65 71.05 USD |
+1.56
|
$11.98B 13.09B USD | $0 0 USD | $65 71.05 USD | $65 71.05 USD | $11.98B 13.09B USD | 0 | -$5.21 -5.6 USD | |
| WuXi Biologics (Cayman) WXIBF | $3.2 — |
+6.67
|
$13.07B — | $200.4K — | $3.2 — | $3.2 — | $13.07B — | 29.09 | $0.11 — | |
| Genmab A/S GMAB.VI | $190.4 208.13 USD |
-1.32
|
$11.73B 12.82B USD | $0 0 USD | $190.4 208.13 USD | $192.1 209.99 USD | $11.73B 12.82B USD | 12.79 | $14.88 16.27 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $164 33.24 USD |
0
|
$62.9B 12.75B USD | $0 0 USD | $164 33.24 USD | $164 33.24 USD | $62.9B 12.75B USD | 21.55 | $7.61 1.54 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Incyte Corporation ICY.F | $58.84 64.32 USD |
+0.1
|
$11.48B 12.55B USD | $17 18.58 USD | $58.84 64.32 USD | $58.84 64.32 USD | $11.48B 12.55B USD | 326.88 | $0.18 0.2 USD | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.76 3.02 USD |
-3.12
|
$11.23B 12.28B USD | $840 918.23 USD | $2.73 2.98 USD | $2.76 3.02 USD | $11.23B 12.28B USD | 27.60 | $0.1 0.11 USD | |
| Moderna, Inc. MRNA.MX | $523.76 31.01 USD |
0
|
$203.06B 12.02B USD | $288 17.05 USD | $523.76 31.01 USD | $523.76 31.01 USD | $203.06B 12.02B USD | 0 | -$168 -9.9 USD | |
| Ascendis Pharma A/S A1SN34.SA | $66.1 13.4 USD |
0
|
$59.27B 12.01B USD | $0 0 USD | $66.1 13.4 USD | $66.1 13.4 USD | $59.27B 12.01B USD | 0 | -$37.31 -7.5 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.4 5.9 USD |
-3.57
|
$10.99B 12.01B USD | $208 227.37 USD | $5.4 5.9 USD | $5.4 5.9 USD | $10.99B 12.01B USD | 28.42 | $0.19 0.21 USD | |
| Exelixis, Inc. EX9.F | $36.62 40.03 USD |
-1.48
|
$9.99B 10.92B USD | $230 251.42 USD | $36.62 40.03 USD | $36.62 40.03 USD | $9.99B 10.92B USD | 18.97 | $1.93 2.11 USD | |
| Verona Pharma plc I9SA.F | $76.4 83.52 USD |
+0.53
|
$9.88B 10.8B USD | $260 284.22 USD | $76.4 83.52 USD | $76.4 83.52 USD | $9.88B 10.8B USD | 0 | -$1.76 -1.9 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.55 — |
-3.37
|
$10.54B — | $1.26K — | $0.55 — | $0.55 — | $10.54B — | 55.27 | $0.01 — | |
| Sino Biopharmaceutical SBHMY | $9.48 — |
+7.85
|
$10.54B — | $321 — | $9.48 — | $9.48 — | $10.54B — | 32.68 | $0.29 — | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $49.12 53.69 USD |
-1.41
|
$9.42B 10.3B USD | $0 0 USD | $49.12 53.69 USD | $49.22 53.8 USD | $9.42B 10.3B USD | 20.81 | $2.36 2.58 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $48.92 53.48 USD |
-1.61
|
$9.38B 10.26B USD | $50 54.66 USD | $48.91 53.47 USD | $48.92 53.48 USD | $9.38B 10.26B USD | 20.64 | $2.37 2.59 USD | |
| Moderna, Inc. 0QF.MU | $23.98 26.21 USD |
-2.36
|
$9.27B 10.14B USD | $0 0 USD | $23.98 26.21 USD | $23.98 26.21 USD | $9.27B 10.14B USD | 0 | -$7.67 -8.3 USD | |
| Moderna, Inc. MRNA.VI | $23.98 26.21 USD |
-1.42
|
$9.27B 10.14B USD | $0 0 USD | $23.9 26.13 USD | $24.03 26.27 USD | $9.27B 10.14B USD | 0 | -$7.62 -8.3 USD | |
| Moderna, Inc. 0QF.F | $23.97 26.2 USD |
-2.94
|
$9.27B 10.13B USD | $715 781.59 USD | $23.68 25.89 USD | $24.09 26.33 USD | $9.27B 10.13B USD | 0 | -$7.67 -8.3 USD | |
| Ascendis Pharma A/S A71.F | $151 165.06 USD |
-1.31
|
$9.13B 9.99B USD | $60 65.59 USD | $151 165.06 USD | $151 165.06 USD | $9.13B 9.99B USD | 0 | -$5.81 -6.3 USD | |
| Akeso, Inc. 4RY.F | $9.05 9.89 USD |
+1.12
|
$8.25B 9.01B USD | $172 188.02 USD | $9.05 9.89 USD | $9.1 9.95 USD | $8.25B 9.01B USD | 0 | -$0.07 -0.07 USD | |
| Bio-Techne Corporation T1CH34.SA | $9.39 1.9 USD |
+2.29
|
$44.16B 8.95B USD | $0 0 USD | $0 0 USD | $0 0 USD | $44.16B 8.95B USD | 58.68 | $0.16 0.03 USD | |
| Bio-Techne Corporation TECH.MX | $939.69 55.64 USD |
-36.03
|
$149.31B 8.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.31B 8.84B USD | 36.99 | $25.4 1.5 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Cerevel Therapeutics CERE | $44.96 — |
0
|
$8.19B — | $0 — | $0 — | $0 — | $8.19B — | 0 | $0 — | |
| Blueprint Medicines Corporation 2L9.F | $111.5 121.88 USD |
-1.28
|
$7.2B 7.87B USD | $120 131.18 USD | $111.5 121.88 USD | $111.5 121.88 USD | $7.2B 7.87B USD | 0 | -$2.2 -2.4 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $1,008.77 59.73 USD |
0
|
$127.76B 7.56B USD | $270 15.99 USD | $1,008.77 59.73 USD | $1,008.77 59.73 USD | $127.76B 7.56B USD | 13.92 | $72.43 4.29 USD | |
| Bio-Techne Corporation TE1.F | $43 47 USD |
-0.92
|
$6.8B 7.44B USD | $50 54.66 USD | $43 47 USD | $43 47 USD | $6.8B 7.44B USD | 58.90 | $0.73 0.8 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $0 0 USD | $0 0 USD | $0 0 USD | $6.79B 7.42B USD | 0 | $0 0 USD | |
| Roivant Sciences Ltd. 87S.F | $9.71 10.61 USD |
+1.17
|
$6.75B 7.38B USD | $600 655.88 USD | $9.7 10.6 USD | $9.71 10.61 USD | $6.75B 7.38B USD | 0 | -$0.66 -0.7 USD | |
| Revolution Medicines, Inc. 42Z.F | $35 38.26 USD |
-0.57
|
$6.57B 7.18B USD | $86 94.01 USD | $35 38.26 USD | $35 38.26 USD | $6.57B 7.18B USD | 0 | -$3.52 -3.8 USD | |
| Corcept Therapeutics Incorporated HTD.F | $60.76 66.42 USD |
-0.56
|
$6.48B 7.09B USD | $115 125.71 USD | $60.66 66.31 USD | $60.76 66.42 USD | $6.48B 7.09B USD | 60.15 | $1.01 1.1 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $32.97 36.04 USD |
+0.83
|
$6.39B 6.99B USD | $100 109.31 USD | $32.97 36.04 USD | $32.97 36.04 USD | $6.39B 6.99B USD | 0 | -$3.13 -3.4 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $18.75 20.5 USD |
-3.1
|
$6.34B 6.93B USD | $50 54.66 USD | $18.75 20.5 USD | $18.75 20.5 USD | $6.34B 6.93B USD | 0 | -$4.43 -4.8 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $46.94 51.31 USD |
+0.28
|
$5.85B 6.39B USD | $200 218.63 USD | $46.94 51.31 USD | $46.94 51.31 USD | $5.85B 6.39B USD | 14.22 | $3.3 3.61 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $94.6 103.41 USD |
-1.56
|
$5.83B 6.38B USD | $20 21.86 USD | $94.58 103.39 USD | $94.6 103.41 USD | $5.83B 6.38B USD | 14.62 | $6.47 7.07 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $647 38.31 USD |
0
|
$107.59B 6.37B USD | $0 0 USD | $0 0 USD | $0 0 USD | $107.59B 6.37B USD | 0 | -$57.57 -3.4 USD | |
| Financière de Tubize SA FTD.SG | $127.4 139.27 USD |
+1.43
|
$5.67B 6.2B USD | $0 0 USD | $126.4 138.17 USD | $127.4 139.27 USD | $5.67B 6.2B USD | 63.06 | $2.02 2.21 USD | |
| ALK-Abelló A/S AKBLF | $26.99 — |
+4.01
|
$6.18B — | $2 — | $26.99 — | $27.05 — | $6.18B — | 42.17 | $0.64 — | |
| Financière de Tubize SA FTD.F | $126.4 138.17 USD |
+0.64
|
$5.63B 6.15B USD | $70 76.52 USD | $126.4 138.17 USD | $126.4 138.17 USD | $5.63B 6.15B USD | 62.57 | $2.02 2.21 USD | |
| ALK-Abelló A/S 4AJ0.F | $24.62 26.91 USD |
+0.08
|
$5.43B 5.94B USD | $2 2.19 USD | $24.28 26.54 USD | $24.66 26.96 USD | $5.43B 5.94B USD | 43.96 | $0.56 0.61 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $242.3 264.87 USD |
-0.82
|
$5.4B 5.91B USD | $45 49.19 USD | $242.3 264.87 USD | $242.3 264.87 USD | $5.4B 5.91B USD | 0 | -$15.67 -17.1 USD | |
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
||||||||||